These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 17073941)
1. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice. Ju ZL; Shi GY; Zuo JX; Zhang JW; Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941 [TBL] [Abstract][Full Text] [Related]
2. OBF-1 is essential for the generation of antibody-secreting cells and the development of autoimmunity in MRL-lpr mice. Zuo J; Ge H; Zhu G; Matthias P; Sun J J Autoimmun; 2007; 29(2-3):87-96. PubMed ID: 17574818 [TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501 [TBL] [Abstract][Full Text] [Related]
4. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185 [TBL] [Abstract][Full Text] [Related]
5. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice]. Kobayashi K; Hamano T; Kakishita E Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824 [TBL] [Abstract][Full Text] [Related]
6. KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus. Lee GH; Oh JM; Kim HS; Yoon WK; Yi KY; Yang Y; Han SH; Lee S; Moon EY Eur J Pharmacol; 2011 Oct; 668(3):459-66. PubMed ID: 21827747 [TBL] [Abstract][Full Text] [Related]
7. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655 [TBL] [Abstract][Full Text] [Related]
8. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF). Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004 [TBL] [Abstract][Full Text] [Related]
9. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Yajima K; Nakamura A; Sugahara A; Takai T Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068 [TBL] [Abstract][Full Text] [Related]
10. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. Klinman DM; Eisenberg RA; Steinberg AD J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800 [TBL] [Abstract][Full Text] [Related]
11. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
12. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922 [TBL] [Abstract][Full Text] [Related]
13. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978 [TBL] [Abstract][Full Text] [Related]
14. B cell genotype determines the fine specificity of autoantibody in lpr mice. Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626 [TBL] [Abstract][Full Text] [Related]
15. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. Chan O; Shlomchik MJ J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955 [TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [TBL] [Abstract][Full Text] [Related]
17. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice. Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657 [TBL] [Abstract][Full Text] [Related]
18. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365 [TBL] [Abstract][Full Text] [Related]
19. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma. Klinman DM J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205 [TBL] [Abstract][Full Text] [Related]
20. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF. Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]